메뉴 건너뛰기
New England Journal of Medicine
Volumn 369, Issue 7, 2013, Pages 678-679
Sofosbuvir for previously untreated chronic hepatitis C infection
Author keywords

[No Author keywords available]
Indexed keywords

INTERFERON; RIBAVIRIN; SOFOSBUVIR; VIRUS RNA;
EID: 84881469486     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1307641     Document Type: Letter
Times cited : (41)
References (3)
  • 1
    • 84877730954 scopus 로고    scopus 로고
    • Sofosbuvir for previously untreated chronic hepatitis C infection
    • Lawitz E, Mangia A, Wyles D, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 2013;368:1878-87.
    • (2013) N Engl J Med , vol.368 , pp. 1878-1887
    • Lawitz, E.1    Mangia, A.2    Wyles, D.3
  • 2
    • 77951745893 scopus 로고    scopus 로고
    • Outcomes of HCV treatment: Who does well and who does not?
    • Hsu CS, Kao JH. Outcomes of HCV treatment: who does well and who does not? J Gastroenterol Hepatol 2010;25:846-8.
    • (2010) J Gastroenterol Hepatol , vol.25 , pp. 846-848
    • Hsu, C.S.1    Kao, J.H.2
  • 3
    • 2442683905 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3
    • Erratum, J Hepatol 2005;42:434
    • Zeuzem S, Hultcrantz R, Bourliere M, et al. Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3. J Hepatol 2004;40:993-9. [Erratum, J Hepatol 2005;42:434.]
    • (2004) J Hepatol , vol.40 , pp. 993-999
    • Zeuzem, S.1    Hultcrantz, R.2    Bourliere, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.